Diabetic macular edema (DME) and diabetic retinopathy (DR) are complications affecting
about 25% of all patients with long-standing type 1 and type 2 diabetes mellitus and are a …

Vitreous fluid levels of vascular endothelial growth factor (VEGF), soluble VEGF receptor
(sVEGFR)-2, soluble intercellular adhesion molecule (sICAM)-1, monocyte chemotactic …

Modern diagnostic and treatment aspects of diabetic macular edema | Doga | Diabetes
mellitus Diabetes mellitus eng | рус User ISSN 2072-0351 (Print) ISSN 2072-0378 (Online) …

The pathogenesis of diabetic macular edema (DME) is complex. Persistently high blood
glucose activates multiple cellular pathways and induces inflammation, oxidation stress, and …

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes and
the leading cause of visual impairment in the working-age population in the Western world …

Diabetic macular edema (DME) can cause blindness in diabetic patients suffering from
diabetic retinopathy (DR). DM parameters controls (glycemia, arterial tension, and lipids) are …

Diabetic retinopathy, characterized as a microangiopathy and neurodegenerative disease,
is the leading cause of visual impairment in diabetic patients. Many clinical features …

Diabetic macular edema (DME) affects up to 29% of patients with diabetic retinopathy (DR)
and is the most frequent cause of visual impairment in these patients (Klein, Klein, Moss …

Diabetic macular oedema (DMO) is an important cause of vision loss in patients with
diabetes mellitus. The underlying mechanisms of DMO, on both macrocellular and …

Diabetic retinopathy (DR), the most common microvascular complication of diabetes
mellitus, is estimated to be the leading cause of new blindness in the working population of …